Long-term oral glucocerebrosidase activator reduces soluble α-synuclein oligomer accumulation in Parkinsonian LRRK2 mutant mouse brain

Related articles

1. The Parkinson’s Disease Associated BAP1/ASXL3 Complex Regulates the Internalization of α-Synuclein Fibrils by Reprogramming the Cell Surface Glycoproteome

   This article has 26 authors:

   1. Nathan C. Karpilovsky
   2. Thomas Goiran
   3. Konstantin Senkevich
   4. Ghislaine Deyab
   5. Nicholas Twells
   6. Emily NaYoung Cha
   7. Emma Macdougall
   8. Zhangjie Wang
   9. Julien Sirois
   10. Graham Macleod
   11. Lang Liu
   12. Morvarid Ghamgosar Shahkhali
   13. Kalidou Ali Boubacar
   14. Jace Jones-Tabah
   15. Isabella Pietrantonio
   16. Wen Luo
   17. Irina Shlaifer
   18. Esther Del Cid-Pellitero
   19. Ayodeji Kulepa
   20. El Bachir Affar
   21. Stephane Angers
   22. Jian Liu
   23. Lara K. Mahal
   24. Thomas M. Durcan
   25. Ziv Gan-Or
   26. Edward A. Fon

2. Oral administration of dibenzoylmethane (DBM) prevents cognitive decline in a C9ORF72-mediated FTD mouse model

   This article has 18 authors:

   1. Paulina Torres
   2. Daniela Becerra
   3. José I. Astorga
   4. Matías Fuentealba
   5. Grant Kauwe
   6. Luis Gonzalez
   7. Guillermo Diaz
   8. Vania Morales
   9. Vicente Valenzuela
   10. Cameron Wehrfritz
   11. Yani Y. Ngwala
   12. Claudia Sepulveda-Quiñenao
   13. Samah Shah
   14. Joanna Bons
   15. Leonard Petrucelli
   16. Tara E. Tracy
   17. Birgit Schilling
   18. Claudio Hetz

3. Aberrant accumulation of α-synuclein might be linked with the progressive motor deficits in a mouse model of Angelman syndrome

   This article has 3 authors:

   1. Sagarika Das
   2. Bhaskarjyoti Giri
   3. Nihar Ranjan Jana